Fulbright & Jaworski L.L.P.
Methods and compositions involving miRNA and miRNA inhibitor molecules
The present invention concerns methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules. Moreover, the present invention concerns methods and compositions for identifying miRNAs with specific cellular functions that are relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic miRNAs and/or miRNA inhibitors are used in library screening assays.
Asuragen, Inc.
A C C C C A C C A C C C A C C C A C A C C C A C A C A C A A C A C A A A A A A C A C
A61P C12N C12Q C12N C12Q A61P C12N C12N A61P C12N C12N C12N A61K C12N C12Q C12N A61K C12N A61P C12N C12N C12N A61P C12N A61K C12N A61P C12N A61K A61P C12N A61P C12Q A61N A61K A61P A61P A61P A61P C12N A61P C12N
inventional additional additional additional additional inventional additional additional inventional additional additional additional inventional inventional inventional inventional inventional additional inventional additional additional additional inventional additional inventional additional inventional additional inventional inventional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional additional
Angie Kevin Lance Dmitriy David Mike Eric Rich
Cheng Kelnar Ford Ovcharenko Brown Byrom Devroe Jarvis